Inappropriate Colorectal Cancer Screening: Findings and Implications

Fisher, Deborah A.; Judd, Latisha; Sanford, Nadia S.
November 2005
American Journal of Gastroenterology;Nov2005, Vol. 100 Issue 11, p2526
Academic Journal
OBJECTIVES: Inclusion of colorectal cancer screening as a performance measure in the Veterans Health Administration (VHA) health system appears to have improved screening rates but may have also increased inappropriate screening. Our aim was to ascertain whether the fecal occult blood test (FOBT) was being ordered appropriately. METHODS: We examined records of 500 consecutive primary care patients at a single VHA facility for whom FOBT had been ordered to determine whether the FOBT was appropriate and, if not, the reason why. RESULTS: We found that 18% of the sample had severe comorbid illness, 13% had signs or symptoms of gastrointestinal blood loss, 7% had a history of colorectal neoplasia or inflammatory bowel disease (high risk), 5% had undergone colonoscopy within prior 5 yr, and 3% were younger than 50 yr of age. Overall, 35% of the patients had at least one reason that the FOBT was inappropriate and at least 19% of the patients should not have undergone any colorectal cancer test for screening or diagnosis. CONCLUSIONS: The FOBT order was inappropriate in a third of the sample, most commonly because of a documented life-limiting comorbidity. In addition, data suggested that FOBT was being used for diagnosis instead of screening. Screening patients unlikely to live long enough to develop and die from colorectal cancer provides no benefit and places these individuals at unjustifiable risk. Additionally, inappropriate screening utilizes resources that could be used to improve screening and follow-up for eligible individuals.


Related Articles

  • CT colonography with limited bowel preparation for the detection of colorectal neoplasia in an FOBT positive screening population. Liedenbaum, Marjolein; Vries, Ayso; Rijn, Anne; Dekker, Helena; Willemssen, François; Leerdam, Monique; Marrewijk, Corine; Fockens, Paul; Bipat, Shandra; Bossuyt, Patrick; Dekker, Evelien; Stoker, Jaap; Liedenbaum, Marjolein H; de Vries, Ayso H; van Rijn, Anne F; Dekker, Helena M; Willemssen, François E J A; van Leerdam, Monique E; van Marrewijk, Corine J; Bossuyt, Patrick M M // Abdominal Imaging;Nov/Dec2010, Vol. 35 Issue 6, p661 

    Purpose: Aim was to evaluate the accuracy of computed tomography colonography (CTC) for detection of colorectal neoplasia in a Fecal Occult Blood Test (FOBT) positive screening population. Methods: In three different institutions, consecutive FOBT positives underwent...

  • Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies. Sharaf, Ravi N; Ladabaum, Uri // American Journal of Gastroenterology;Jan2013, Vol. 108 Issue 1, p120 

    OBJECTIVES:Fecal occult blood testing (FOBT) and sigmoidoscopy are proven to decrease colorectal cancer (CRC) incidence and mortality. Sigmoidoscopy's benefit is limited to the distal colon. Observational data are conflicting regarding the degree to which colonoscopy affords protection against...

  • Plasma microRNAs: a potential biomarker for colorectal cancer? Schetter, Aaron J.; Harris, Curtis C. // Gut;Oct2009, Vol. 58 Issue 10, p1318 

    In this article, the author discusses the potential biomarker for colorectal cancer (CRC). It suggests the importance to improve early detection screening methods for CRC using colonoscopy as a reliable and acurate screening tool. It shows that faecal occult blood tests (FOBT) are effective to...

  • Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population. Yang, Haiyun; Ge, Zhizheng; Dai, Jun; Li, Xiaobo; Gao, Yunjie // Digestive Diseases & Sciences;Jan2011, Vol. 56 Issue 1, p203 

    Background: Guaiac tests are the most widely used tests to detect colorectal cancer (CRC). However, their sensitivity is relatively low and results may be affected by various factors. Immunofecal occult blood test (IFOBT) is specific for human hemoglobin and does not require dietary...

  • Primary screening with colonoscopy for colorectal cancer: a targeted algorithm? Byrne, Michael F. // American Journal of Gastroenterology;Dec2003, Vol. 98 Issue 12, p2587 

    Introduces articles in the December 2003 issue of the "American Journal of Gastroenterology". Study investigating the use of colonoscopy as a primary screening test for colorectal cancer (CRC) in average risk people; Absence of randomized trials to support screening colonoscopy; Studies in Great...

  • SCREENINGUL CANCERULUI COLORECTAL LA POPULAÅ¢IA CU RISC MEDIU DIN JUDEÅ¢UL SUCEAVA. Croitoru, Liliana; Trifan, Anca; Stanciu, C. // Jurnalul de Chirurgie;2010, Vol. 6 Issue 4, p467 

    Colorectal cancer (CRC) is the second leading cause of cancer death both in the USA and Europe. Although CRC is the most preventable visceral form of cancer, there is tremendous variation in screening practices around the world and most people do not have access to CRC screening. In Romania, the...

  • Patient information: What you need to know about colon screening.  // Patient Care for the Nurse Practitioner;Aug2002, Vol. 5 Issue 8, p15 

    The article provides information on colon cancer screening. The disease is the second leading cause of cancer-related deaths in the U.S. According to the American Cancer Society guidelines for the early detection of cancer of such type, starting at age 50, both men and women should have fecal...

  • In your best interests. Handley, Alison // Nursing Standard;4/21/2010, Vol. 24 Issue 33, p18 

    Nurses in Birmingham are raising awareness of the national bowel cancer screening programme throughout their diverse community.

  • Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer Screening. Dong Il Park; Seungho Ryu; Young-Ho Kim; Suck-Ho Lee; Chang Kyun Lee; Chang Soo Eun; Dong Soo Han // American Journal of Gastroenterology;Sep2010, Vol. 105 Issue 9, p2017 

    OBJECTIVES:Although some studies have shown that the quantitative, immunochemical fecal occult blood test (FOBT) (qFIT) has better performance characteristics than the standard guaiac-based FOBT (GT) for identifying advanced colorectal neoplasia (ACRN), there is limited information on test...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics